UK markets closed
NIKKEI 225
38,405.66 +470.90 (+1.24%) HANG SENG
17,763.03 +16.12 (+0.09%) CRUDE OIL
81.69 -0.94 (-1.14%) GOLD FUTURES
2,303.90 -53.80 (-2.28%) DOW
37,932.61 -453.48 (-1.18%) Bitcoin GBP
48,046.11 -2,139.90 (-4.26%)
Coherus BioSciences, Inc. (CHRS)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
As of 03:47PM EDT. Market open.
| Previous close | 2.0700 |
| Open | 2.0500 |
| Bid | 1.9700 x 100 |
| Ask | 1.9800 x 100 |
| Day's range | 1.9600 - 2.0875 |
| 52-week range | 1.4300 - 8.2200 |
| Volume | |
| Avg. volume | 2,567,882 |
| Market cap | 224.159M |
| Beta (5Y monthly) | 0.51 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Simply Wall St.
Investors in Coherus BioSciences (NASDAQ:CHRS) have unfortunately lost 83% over the last five years
Long term investing is the way to go, but that doesn't mean you should hold every stock forever. We really hate to see...
- Insider Monkey
Coherus BioSciences, Inc. (NASDAQ:CHRS) Q4 2023 Earnings Call Transcript
Coherus BioSciences, Inc. (NASDAQ:CHRS) Q4 2023 Earnings Call Transcript March 13, 2024 Coherus BioSciences, Inc. misses on earnings expectations. Reported EPS is $-0.62 EPS, expectations were $-0.21. CHRS isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day, and thank […]
- Simply Wall St.
Coherus BioSciences Full Year 2023 Earnings: EPS Misses Expectations
Coherus BioSciences ( NASDAQ:CHRS ) Full Year 2023 Results Key Financial Results Revenue: US$257.2m (up 22% from FY...
© 2024 Yahoo. All rights reserved.